Whalesbook
IVL's Strategic Play for EPL
This move shows Indorama Ventures (IVL) consolidating control over EPL using a share-swap method that avoids traditional public buyouts. The agreement, expected to finalize within a year, will allow IVL to integrate EPL's steady specialty packaging business into its own operations. IVL's current business faces valuation challenges, reflected in its negative P/E ratio.
How IVL Aims for EPL Control
The deal proceeds in two steps. First, IVL bought a 24.8% stake from Blackstone in May 2025 for Rs 240 per share. The next, more complex step involves merging IVL's unlisted Indian unit, Indovida India, into EPL. This share-swap structure gives IVL just under 52% ownership, granting it formal promoter control. It will dilute public shareholders from 46% to about 31% and reduce Blackstone's stake from 26% to under 17%. Blackstone will keep a board seat, suggesting ongoing influence.
Both sides agreed on a Rs 339 per share valuation for EPL, a 70% premium over its trading price of around Rs 199 before the announcement. This values EPL at roughly INR 11,000 crore. Indovida, IVL's packaging arm, is valued at INR 6,250 crore, making the combined entity worth about $2 billion (Rs 17,250 crore). While public shareholders face dilution, the strategy aims to make the merger boost earnings per share and margins.
Valuation Differences and Market Trends
The valuation difference is significant: EPL's specialty laminated tube business is valued at about 12.5 times trailing EBITDA, while Indovida's PET preform and bottle operations are valued much lower, at 7.5 times. This lower valuation for Indovida stems from market perception, as PET preforms are seen as more of a commodity than EPL's specialty tubes. However, Indorama Ventures' own financial performance presents a stark contrast. As of April 2026, IVL reported a trailing twelve-month P/E ratio of -65.8, indicating significant losses or a major earnings gap compared to its market value. This is very different from EPL's TTM P/E ratio, which is between 17.5x and 22.95x, typical for its industry.
The global packaging market is expected to grow, with the overall market reaching USD 1.28 trillion in 2025 and projected expansion. The tube packaging segment is forecast to reach USD 16.05 billion by 2033, growing at a 5.73% CAGR. Laminated tubes specifically are expected to grow from USD 2.8 billion in 2025 to USD 5.2 billion by 2035 at a 6.4% CAGR. EPL holds about 15.4% of the laminated tubes market. In contrast, the PET preform market, where Indovida operates, is growing more slowly at a 2.17% CAGR and is considered more commodity-driven.
IVL's strategy seems focused on using the higher valuations typically given to Indian listed companies for its own less-valued businesses. This is part of its broader 'IVL 2.0' strategy to improve margins and reduce debt. The company aims to increase EBITDA from THB 32 billion in 2025 to THB 64 billion by 2028.
Concerns Over the Deal Structure
The Rs 339/share valuation for EPL in this share swap looks high, especially compared to the Rs 240/share cash deal just a year ago and IVL's own poor financial figures. IVL's negative P/E ratio suggests major problems, making its move to control EPL, a better-valued company, questionable. Indovida itself is described as an "engineered" entity, created for this merger, and its full financial picture has not yet been revealed. This lack of clarity adds to the risk.
The merger process is taking a long time, expected to take another 12 months for regulatory and shareholder approvals. This adds uncertainty, especially with global tensions and volatile energy markets affecting supply chains. The shift from a cash deal to a share swap, valuing EPL higher, primarily helps IVL gain control without a large cash payment, effectively trading its own low-valued shares for EPL's higher-valued assets. While laminated tubes are key for EPL, they face scrutiny over recyclability, contrasting with the trend towards simpler packaging materials.
Outlook for Investors
Although EPL's management expects the merger to boost earnings per share, EBIT margins, and ROCE from the first full year, this depends on successfully integrating Indovida and achieving expected benefits. EPL's current market valuation, around ₹226 per share, already reflects a significant rise over the past year, returning about 19.5%. Investors must consider the potential benefits against structural risks, the dilutive effect of the share swap, and market trends favoring sustainability and simpler packaging, all while IVL works on its own financial recovery.